Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.2.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2024
Oct. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,225 $ 915
Short-term investments 19,520 22,929
Receivables 410 270
Prepaid expenses and other current assets 1,515 1,242
Total current assets 22,670 25,356
Operating lease right-of-use asset 238 166
Total assets 22,908 25,522
Current liabilities:    
Accounts payable 302 206
Accrued expenses 1,678 1,770
Operating lease liability 24 52
Total current liabilities 2,004 2,028
Operating lease liability, non-current 213 123
Total liabilities 2,217 2,151
Commitments and contingencies (Note 10)
Equity:    
Preferred stock, value
Common stock, par value $.01 per share; 100,000,000 shares authorized; 32,146,460 and 31,145,219 shares issued and outstanding as of July 31, 2024 and October 31, 2023, respectively 321 311
Additional paid-in capital 259,317 252,222
Accumulated deficit (237,867) (228,196)
Total shareholders’ equity 21,771 24,337
Noncontrolling interest (Note 2) (1,080) (966)
Total equity 20,691 23,371
Total liabilities and equity 22,908 25,522
Series A Convertible Preferred Stock [Member]    
Equity:    
Preferred stock, value